02. July 2009
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion
Roche announced today that the Phase III study BRAVO showed Lucentis (ranibizumab injection) improved vision, as measured by the primary endpoint of mean change from baseline in best-corrected visual acuity at six months, in patients with macular edema due to branch retinal vein occlusion. more
- 02. July 2009
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion - 01. July 2009
Roche launches novel program to ease Tamiflu access to developing economies - 11. June 2009
New data demonstrate the ability of MabThera to reduce the progression of joint damage when used as a first-line biologic treatment in rheumatoid arthritis
Services
- Contacts
- Media Archive
- Photolibrary
- Download Corporate Brochures
- RSS-Feeds
- Roche Events Podcast
- Subscribe to Roche News
Upcoming Events
-
July 23 2009
Half-Year Results -
October 15 2009 (tentative)
Third quarter sales